![](/img/cover-not-exists.png)
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia
Frolova, Olga, Benito, Juliana, Brooks, Chris, Wang, Rui-Yu, Korchin, Borys, Rowinsky, Eric K., Cortes, Jorge, Kantarjian, Hagop, Andreeff, Michael, Frankel, Arthur E., Konopleva, MarinaVolume:
166
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12978
Date:
September, 2014
File:
PDF, 682 KB
english, 2014